OIM
Oracle Investment Management Portfolio holdings
AUM
$116M
This Quarter Return
-2.54%
1 Year Return
+84.31%
3 Year Return
+539.5%
5 Year Return
+791.07%
10 Year Return
+13,222.09%
AUM
$65.1M
AUM Growth
+$65.1M
(-39%)
Cap. Flow
-$30.2M
Cap. Flow
% of AUM
-46.44%
Top 10 Holdings %
Top 10 Hldgs %
94.84%
Holding
25
New
3
Increased
4
Reduced
9
Closed
5
Top Buys
| 1 |
MannKind Corp
MNKD
|
$1.24M |
| 2 |
NSTG
NanoString Technologies, Inc.
NSTG
|
$836K |
| 3 |
GeneDx Holdings
WGS
|
$469K |
| 4 |
Biohaven
BHVN
|
$254K |
| 5 |
Ardelyx
ARDX
|
$204K |
Top Sells
| 1 |
AXDX
Accelerate Diagnostics
AXDX
|
$7.9M |
| 2 |
Opko Health
OPK
|
$6.07M |
| 3 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$5.51M |
| 4 |
QuidelOrtho
QDEL
|
$3.96M |
| 5 |
Pacific Biosciences
PACB
|
$3.15M |
Sector Composition
| 1 | Healthcare | 99.83% |
| 2 | Energy | 0.17% |
| 3 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Biohaven
BHVN
$1.63B
| $15.8M | 4.85% |
607,527
+9,754
| +2% | +$254K |
|
|
2
QuidelOrtho
QDEL
$1.95B
| $14M | 4.29% |
191,244
-54,251
| -22% | -$3.96M |
|
|
3
Pacific Biosciences
PACB
$393M
| $13.7M | 4.2% |
1,638,395
-377,100
| -19% | -$3.15M |
|
4
BioCryst Pharmaceuticals
BCRX
$1.74B
| $3.93M | 1.21% |
555,522
| – | – |
|
|
5
GeneDx Holdings
WGS
$3.72B
| $3.62M | 1.11% |
994,580
+128,731
| +15% | +$469K |
|
|
6
Ardelyx
ARDX
$1.53B
| $3.06M | 0.94% |
749,700
+50,000
| +7% | +$204K |
|
7
Forian
FORA
$61.3M
| $3.05M | 0.94% |
1,368,067
+3,738
| +0.3% | +$8.34K |
|
|
AGEN
8
Agenus
AGEN
$133M
| $2.39M | 0.73% |
2,116,963
-939,497
| -31% | -$1.06M |
|
|
9
MannKind Corp
MNKD
$1.41B
| $1.24M | 0.38% |
+300,000
| New | +$1.24M |
|
|
IMMP
10
Immutep
IMMP
$234M
| $981K | 0.3% |
516,430
-377,961
| -42% | -$718K |
|
|
NSTG
11
DELISTED
NanoString Technologies, Inc.
NSTG
| $836K | 0.26% |
+485,886
| New | +$836K |
|
|
AXDX
12
DELISTED
Accelerate Diagnostics
AXDX
| $785K | 0.24% |
136,528
-1,374,126
| -91% | -$7.9M |
|
|
13
Opko Health
OPK
$1.1B
| $721K | 0.22% |
450,564
-3,791,901
| -89% | -$6.07M |
|
14
Biogen
BIIB
$19.4B
| $620K | 0.19% |
2,412
| – | – |
|
|
VTNR
15
DELISTED
Vertex Energy, Inc
VTNR
| $113K | 0.03% |
25,300
-75,100
| -75% | -$334K |
|
|
OMGA
16
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $108K | 0.03% |
50,000
-147,449
| -75% | -$317K |
|
17
Biodesix
BDSX
$62.6M
| $69.4K | 0.02% |
+42,076
| New | +$69.4K |
|
|
DMTK
18
DELISTED
DermTech, Inc. Common Stock
DMTK
| $68.7K | 0.02% |
47,687
| – | – |
|
19
MiNK Therapeutics
INKT
$64.4M
| $40.6K | 0.01% |
36,898
-13,563
| -27% | -$14.9K |
|
|
BPMC
20
DELISTED
Blueprint Medicines
BPMC
| – | – |
-41,377
| Closed | -$2.62M |
|
21
FibroGen
FGEN
$47.8M
| – | – |
0
| – | – |
|
22
Palantir
PLTR
$372B
| – | – |
-36,700
| Closed | -$563K |
|
23
Surgery Partners
SGRY
$2.91B
| – | – |
-15,000
| Closed | -$675K |
|
24
ProShares UltraPro QQQ
TQQQ
$26B
| – | – |
-70,000
| Closed | -$414K |
|
|
MRTX
25
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| – | – |
-152,600
| Closed | -$5.51M |
|